| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Our speech recognition app is designed to evaluate and give feedback on your English pronunciation and fluency. With ELSA you can speak English like a natural.
Streetlight Information Technologies is a Athens, IL-based company in the Software and Internet sector.
WebForumz is a Lexington, KY-based company in the Software and Internet sector.
The Canadian Email Marketing software built for CASL that will bring you peace of mind. Create stunning newsletters in minutes. Create your free account!